Research Topics
Species | Byung Chul YooSummaryAffiliation: Samsung Medical Center Country: Korea Publications
| Collaborators
|
Detail Information
Publications
Precore and core promoter mutations of hepatitis B virus and hepatitis B e antigen-negative chronic hepatitis B in KoreaByung Chul Yoo
Division of Gastroenterology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
J Hepatol 38:98-103. 2003..The aims of this study were to determine the frequency of precore/core promoter mutations and hepatitis B e antigen (HBeAg)-negative chronic hepatitis B (e-CHB) in Korea...
[Relationship between core gene mutations of hepatitis B virus and response to alpha interferon therapy in chronic hepatitis B]Byung Chul Yoo
Department of Gastroenterology, College of Medicine, Chung Ang University, Seoul, Korea
Taehan Kan Hakhoe Chi 8:381-8. 2002....
Risk factors for relapse in chronic hepatitis C patients who have achieved end of treatment responseSu Rin Shin
Department of Medicine, Kangnam Sacred Hospital, Hallym University, Seoul, Korea
J Gastroenterol Hepatol 25:957-63. 2010..Prolonged therapy can be effective for helping such high-risk patients to avoid relapse. We aimed to identify factors predictive of virologic relapse in chronic hepatitis C patients who have achieved end of treatment response...
Clevudine is highly efficacious in hepatitis B e antigen-negative chronic hepatitis B with durable off-therapy viral suppressionByung Chul Yoo
Sungkyunkwan University Samsung Medical Center, Seoul, South Korea
Hepatology 46:1041-8. 2007..However, treatment for longer than 24 weeks would be needed to achieve durable remission...
Viral response at 6 months is associated with treatment outcome of adefovir add-on therapy for lamivudine-resistanceYu Jin Kim
Department of Medicine, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Korea
J Gastroenterol Hepatol 27:1454-60. 2012..Adefovir add-on therapy is recommended for patients infected with lamivudine-resistant hepatitis B virus (HBV). We aimed to describe the long-term treatment outcome and predictors for good response of adefovir add-on therapy...
Percutaneous radiofrequency ablation for recurrent hepatocellular carcinoma after hepatectomy: long-term results and prognostic factorsDongil Choi
Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50, IlWon Dong, Kangnam Ku, Seoul, 135 710, Korea
Ann Surg Oncol 14:2319-29. 2007....
Frequency and risk factors of renal impairment during long-term adefovir dipivoxil treatment in chronic hepatitis B patientsYu Jin Kim
Department of Medicine, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Korea
J Gastroenterol Hepatol 27:306-12. 2012..There are insufficient data on renal safety during long-term adefovir dipivoxil (ADV) treatment. We aimed to elucidate the incidence and risk factors of renal impairment in chronic hepatitis B (CHB) patients treated with ADV...
Ribavirin dose and treatment outcome of Korean patients with genotype 1 chronic hepatitis CDong Hyun Sinn
Department of Medicine, Samsung Medical Center, Seoul, South Korea
Hepatogastroenterology 59:1-6. 2012..The current recommendation of ribavirin dose for the treatment of chronic hepatitis C is based on study results of Western patients, and might not be optimal for Korean patients because of different body frames...
Upper normal threshold of serum alanine aminotransferase in identifying individuals at risk for chronic liver diseaseHa Na Park
Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
Liver Int 32:937-44. 2012..Serum alanine aminotransferase (ALT) is an easily available, low-cost screening tool for detecting silent chronic liver disease. Recent studies have suggested that the currently accepted healthy ALT thresholds be lowered...
Long-term outcome of preoperative transarterial chemoembolization and hepatic resection in patients with hepatocellular carcinomaJa Young Kang
Department of Internal Medicine, Sungkyunkwan University School of Medicine, Seoul, Korea
Korean J Hepatol 16:383-8. 2010..The long-term outcome of HCC patients receiving TACE prior to hepatic resection is uncertain...
Combined hepatectomy and radiofrequency ablation for multifocal hepatocellular carcinomas: long-term follow-up results and prognostic factorsDongil Choi
Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50, IlWon Dong, Kangnam Ku, Seoul, 135 710, Republic of Korea
Ann Surg Oncol 14:3510-8. 2007..We evaluated the long-term survival results and safety of combined hepatectomy and radiofrequency ablation (RFA) in patients with HCCs and assessed the prognostic factors affecting their survival...
Defining virologic relapse in chronic hepatitis BKyung Hee Kim
Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Irwon dong, Gangnam Gu, Seoul, 135 710, Korea
Dig Dis Sci 56:2432-8. 2011..quot; The aim of this study was to see the effectiveness of these two definitions..
Early three-dimensional conformal radiotherapy for patients with unresectable hepatocellular carcinoma after incomplete transcatheter arterial chemoembolization: a prospective evaluation of efficacy and toxicityDongryul Oh
Departments of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
Am J Clin Oncol 33:370-5. 2010..We prospectively evaluated the efficacy and toxicity of early 3-dimensional conformal radiotherapy (3D-CRT) for patients with unresectable hepatocellular carcinoma (HCC) after incomplete transcatheter arterial chemoembolization (TACE)...
Milan criteria are useful predictors for favorable outcomes in hepatocellular carcinoma patients undergoing liver transplantation after transarterial chemoembolizationDo Young Kim
Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Irwon-dong, Gangnam-gu, 135-710, Seoul, South Korea
World J Gastroenterol 12:6992-7. 2006..3% vs 4.8%; P = 0.90) were not significantly different between the two groups. CONCLUSION: The Milan criteria are still a useful selection criteria showing favorable outcomes in HCC patients receiving TACE before LT...
A clinical predictor of varices and portal hypertensive gastropathy in patients with chronic liver diseaseYang Won Min
Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
Clin Mol Hepatol 18:178-84. 2012....
Clinicopathologic characteristics and long-term prognosis of scirrhous hepatocellular carcinomaJin Hee Lee
Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
Dig Dis Sci 57:1698-707. 2012..Clinicopathologic features and long-term outcomes in patients with scirrhous hepatocellular carcinoma (S-HCC) are not fully defined...
The correlation of hepatitis B virus pre-S mutation with cellular oxidative DNA damage in hepatocellular carcinomaGeum Youn Gwak
Department of Medicine and Digestive Disease Research Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
Hepatogastroenterology 55:2028-32. 2008..Therefore, we investigated the correlation of HBV pre-S mutation with ER stress and cellular oxidative DNA damage in HBV-related HCC patients...
Comparison of usefulness of clinical diagnostic criteria for hepatocellular carcinoma in a hepatitis B endemic areaSo Young Bae
Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
Clin Mol Hepatol 18:185-94. 2012..We compared the accuracy and usefulness of clinical diagnostic criteria for hepatocellular carcinoma in a hepatitis B virus (HBV)-endemic area...
Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution seriesDongil Choi
Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50, IlWon Dong, Kangnam Ku, Seoul, 135 710, South Korea
Eur Radiol 17:684-92. 2007..Percutaneous RFA can be used successfully as a first-line treatment modality for early-stage HCCs. Child-Pugh class, age, and AFP level before RFA were significant prognostic predictors of long-term survival...
Clinical features and prognosis of hepatocellular carcinoma in young patients from a hepatitis B-endemic areaJeong Hwan Kim
Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
J Gastroenterol Hepatol 21:588-94. 2006..Further studies regarding the role of HCC screening in young people may be useful, especially in hepatitis B virus carriers from high endemic areas...
The clinical value of 18F-FDG PET/CT for investigating unexplained serum AFP elevation following interventional therapy for hepatocellular carcinomA Reum Han
Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
Hepatogastroenterology 56:1111-6. 2009....
The correlation of hepatitis B virus pre-S mutation with mitochondrial D-loop mutations and common deletions in hepatocellular carcinomaGeum Youn Gwak
Department of Medicine and Digestive Disease Research Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
Hepatogastroenterology 58:522-8. 2011..We investigated the correlation of HBV pre-S mutation with the sites and frequencies of mtDNA mutations in HCC patients...
Clevudine-induced viral response, associated with continued reduction of HBsAg titer, was durable after the withdrawal of therapyHyo Suk Lee
Seoul National University Hospital, Seoul, Korea
J Gastroenterol 46:410-4. 2011..This study was conducted to evaluate the durability of clevudine-induced viral response after the withdrawal of treatment...
Disease progression and the risk factor analysis for chronic hepatitis CDong Hyun Sinn
Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
Liver Int 28:1363-9. 2008..The present study aimed to assess the incidence of advanced cirrhotic complications and to identify the risk factors associated with such complications in chronic hepatitis C...
[Virologic response to adefovir dipivoxil monotherapy is not durable in HBeAg-positive, lamivudine-resistant chronic hepatitis B patients]Hyun Wook Jung
Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
Korean J Hepatol 15:52-8. 2009..However, little is known about the durability of the virologic response to adefovir in LAMV-R CHB patients...
Seroprevalence of anti-HAV among patients with chronic viral liver diseaseHyun Chin Cho
Division of Gastroenterology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 135 710, South Korea
World J Gastroenterol 17:236-41. 2011..To investigate the current seroprevalence of hepatitis A virus (HAV) antibodies in patients with chronic viral liver disease in Korea. We also tried to identify the factors affecting the prevalence of HAV antibodies...
[Natural history of gastric varices and risk factors for bleeding]Choong Hyeon Lee
Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
Korean J Hepatol 14:331-41. 2008..The aim of this study was to elucidate the natural history of GV bleeding in Korean patients...
Virological response to adefovir monotherapy and the risk of adefovir resistanceDong Hyun Sinn
Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 135 710 Seoul, South Korea
World J Gastroenterol 17:3526-30. 2011..To evaluate virological response to adefovir (ADV) monotherapy and emergence of ADV-resistant mutations in lamivudine (LAM)-resistant chronic hepatitis B patients...
[Antiviral efficacy of lamivudine/adefovir combination therapy in chronic hepatitis b patients with resistance to lamivudine and adefovir consecutively]Hyun Joo Suh
Department of Internal Medicine, Sungkyunkwan University School of Medicine, Samsung Medical Center, Gangnam Gu, Seoul, Korea
Korean J Gastroenterol 53:305-10. 2009..The aim of this study was to elucidate the antiviral efficacy of lamivudine (LMV)-adefovir (ADV) combination therapy in chronic hepatitis B patients who showed resistance to LMV and ADV consecutively...
[Clinical features and predictive factors of acute hepatitis A complicated with acute kidney injury]Jin Hee Lee
Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
Korean J Gastroenterol 56:359-64. 2010..we assessed the clinical features and prognosis of acute viral hepatitis A (AHA) complicated with acute kidney injury (AKI) and elucidated predictive factors for AKI in patients with AHA...
Effect of balloon-occluded retrograde transvenous obliteration on the natural history of coexisting esophageal varicesYong Sung Choi
Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
J Clin Gastroenterol 42:974-9. 2008..The aim of this study was to determine whether the natural history of coexisting EV is affected by BRTO...
Older donor allografts are associated with poor patient survival after living donor liver transplantation for hepatitis B virus-related liver diseasesDo Young Kim
Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
Liver Int 27:260-7. 2007..The significance of donor age in living donor liver transplantation (LDLT) for hepatitis B virus (HBV) infection has not been fully evaluated...
Analysis of the core gene of hepatitis B virus in Korean patientsHyung Joon Kim
Department of Internal Medicine, Chung Ang University Hospital, Seoul, South Korea
Liver Int 27:633-8. 2007....
Long-term results of percutaneous ethanol injection for the treatment of hepatocellular carcinoma in KoreaYon Mi Sung
Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
Korean J Radiol 7:187-92. 2006..Patients with a smaller tumor or a better liver function exhibited superior survival rates...
[Four patients with hepatitis A presenting with fulminant hepatitis and acute renal failure and who underwent liver transplantation]Se Hoon Oh
Department of Internal Medicine, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Korea
Korean J Hepatol 15:362-9. 2009....
Mortality after surgery in patients with liver cirrhosis: comparison of Child-Turcotte-Pugh, MELD and MELDNa scoreHyun Chin Cho
Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
Eur J Gastroenterol Hepatol 23:51-9. 2011....
Clevudine therapy for 24 weeks further reduced serum hepatitis B virus DNA levels and increased ALT normalization rates without emergence of viral breakthrough than 12 weeks of clevudine therapyKwan Sik Lee
Yonsei University Hospital, Seoul, Korea
Intervirology 50:296-302. 2007..The objectives of the study were to evaluate the safety and antiviral activity of 24-week treatment with clevudine 30 mg in HBeAg(+) chronic hepatitis B patients. Biochemical and serological responses were also assessed...
Prognostic index for portal vein tumor thrombosis in patients with hepatocellular carcinoma treated with radiation therapyJeong Il Yu
Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
J Korean Med Sci 26:1014-22. 2011..0%, 17.3% vs 70.1%, 40.8%, respectively, P < 0.001). The PITH scoring model, proposed in the current study in HCC patients with PVTT, reliably predict overall survival...
Ultrasonographically detected non-alcoholic fatty liver disease is an independent predictor for identifying patients with insulin resistance in non-obese, non-diabetic middle-aged Asian adultsDong Hyun Sinn
Department of Medicine, Sungkyunkwan University School of Medicine, Seoul, Korea
Am J Gastroenterol 107:561-7. 2012....
Scheduled interval trans-catheter arterial chemoembolization followed by radiation therapy in patients with unresectable hepatocellular carcinomaJeong Il Yu
Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
J Korean Med Sci 27:736-43. 2012..Other toxicities were manageable. The median survival was 14.7 months. There was a significant difference in overall survival according to the response to START (P < 0.001). In conclusion, START is safe and feasible...
Clinical course of sub-centimeter-sized nodules detected during surveillance for hepatocellular carcinomaYang Won Min
Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 135 710, South Korea
World J Gastroenterol 18:2654-60. 2012..To evaluate the outcome of sub-centimeter-sized nodules (SCSNs) detected during surveillance for hepatocellular carcinoma (HCC) in patients at risk...
Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: analysis of prognostic factorsYoung Sun Kim
Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
J Hepatol 58:89-97. 2013..The aim was to assess 10-year outcomes of radiofrequency ablation as a first-line therapy of early-stage hepatocellular carcinoma with an analysis of prognostic factors...
Clinical significance of core gene mutations during the course of genotype C chronic hepatitis B virus infectionDong Ho Lee
Department of Medicine, Samsung Medical Center, Seoul, Korea
Hepatogastroenterology 58:1643-7. 2011..The aim of this study was to investigate the association of HBV core gene mutations with disease severity in HBV-infected patients...
Predictive factors of gastroduodenal toxicity in cirrhotic patients after three-dimensional conformal radiotherapy for hepatocellular carcinomaHaeyoung Kim
Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
Radiother Oncol 93:302-6. 2009..To identify predictive factors for the development of gastroduodenal toxicity (GDT) in cirrhotic patients treated with three-dimensional conformal radiotherapy (3D-CRT) for hepatocellular carcinoma (HCC)...
Long-term treatment outcomes for autoimmune hepatitis in KoreaJae Sook Kil
Department of Medicine, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Korea
J Korean Med Sci 25:54-60. 2010..This suggests that long-term immunosuppressive therapy may be particularly important for treatment of Korean patients...
A phase II study of oxaliplatin in combination with doxorubicin as first-line systemic chemotherapy in patients with inoperable hepatocellular carcinomaJi Eun Uhm
Division of Hematology Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Irwon dong, Gangnam Gu, Seoul, 135 710, South Korea
Cancer Chemother Pharmacol 63:929-35. 2009..We designed a phase II trial of the combination with oxaliplatin and doxorubicin for patients with unresectable HCC to evaluate the overall response rate (ORR) and the toxicity...
The efficacy of combined transarterial chemoembolization and 3-dimensional conformal radiotherapy for hepatocellular carcinoma with main portal vein thrombosisMoon Kyung Park
Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Irwon dong, Gangnam Gu, 135 710 Seoul, South Korea
Hepatogastroenterology 57:801-6. 2010..The goal of this study was to evaluate the efficacy of combined therapy with TAE and 3-dimensional conformal radiotherapy (3D-CRT) for HCC with main portal vein thrombosis (MPVT)...
Risk factors and a predictive model for acute hepatic failure after transcatheter arterial chemoembolization in patients with hepatocellular carcinomaYang Won Min
Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
Liver Int 33:197-202. 2013..Acute hepatic failure (AHF) is one of the most serious complications of transcatheter arterial chemoembolization (TACE). The aims of this study were to investigate risk factors of AHF after TACE and to establish a predictive model for AHF...
Salvage treatment with hypofractionated radiotherapy in patients with recurrent small hepatocellular carcinomaSun Hyun Bae
Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
Int J Radiat Oncol Biol Phys 82:e603-7. 2012....
[Efficacy and safety of adefovir dipivoxil in patients with decompensated liver cirrhosis with Lamivudine resistance compared to patients with compensated liver disease]Won Moon
Department of Medicine, Gastrointestinal Research Institute, Sungkyunkwan University School of Medicine, Seoul, Korea
Korean J Hepatol 11:125-34. 2005....
[Peginterferon alfa-2a plus ribavirin for initial treatment of chronic hepatitis C in Korea]Hyuk Lee
Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
Korean J Hepatol 12:31-40. 2006..The baseline HCV RNA level and the genotype can be significant factors influencing the SVR...
Analysis of risk factors associated with early multinodular recurrences after hepatic resection for hepatocellular carcinomaJung Ho Park
Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 135-710, Korea
Am J Surg 192:29-33. 2006..Accordingly, an effective adjuvant therapeutic modality should be made available for patients with these risk factors...
Radiation therapy for abdominal lymph node metastasis from hepatocellular carcinomaYoung Je Park
Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Ilwon-dong, Gangnam-gu, Seoul 135-710, Korea
J Gastroenterol 41:1099-106. 2006..However, considering the high rate of RT-induced morbidity, 40 Gy(10) to 50 Gy(10) might be the optimal RT dose...
The efficacy of high-dose 3-dimensional conformal radiation therapy in patients with small hepatocellular carcinoma not eligible for other local modalitiesDo Hoon Lim
Department of Radiation Oncology, Samsung Medical Center, Seoul, Korea
Am J Clin Oncol 36:162-6. 2013..To analyze the efficacy and toxicity of high-dose 3-dimensional conformal radiation therapy (3D-CRT) for patients with small hepatocellular carcinoma (HCC) not eligible for other local modalities...
Tenofovir rescue therapy for chronic hepatitis B patients after multiple treatment failuresYu Jin Kim
Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 135 710, South Korea
World J Gastroenterol 18:6996-7002. 2012..To evaluate the efficacy and safety of tenofovir disoproxil fumarate (TDF) for chronic hepatitis B (CHB) patients after multiple failures...
Change in contrast enhancement of HCC on 1-month follow-up CT after local radiotherapy: an early predictor of final treatment responseEun Young Kim
Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, Kangnam Ku, Seoul 135 710, Republic of Korea
Eur J Radiol 72:440-6. 2009..The purpose of this study was to evaluate the change in contrast enhancement of HCC on 1-month follow-up CT after local radiotherapy (RT) as an early predictor of final treatment response...
A comparison of 48-week treatment efficacy between clevudine and entecavir in treatment-naïve patients with chronic hepatitis BSu Rin Shin
Department of Medicine, Kangnam Sacred Heart Hospital, Hallym University, Seoul, Korea
Hepatol Int 5:664-70. 2011..Clevudine and entecavir are currently available in Korea as antiviral drugs against chronic hepatitis B (CHB). We aimed to compare the efficacy of clevudine and entecavir therapy...
[The age-specific seroprevalence of hepatitis A virus antibody in Korea]Young Bong Song
Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
Korean J Hepatol 13:27-33. 2007..Recently, the prevalence of hepatitis A in young adults has been steadily increasing in Korea. This study is to investigate the age-specific seroprevalence of hepatitis A virus in Korea...
Factors associated with natural seroclearance of hepatitis B surface antigen and prognosis after seroclearance: a prospective follow-up studyJeong Hwan Kim
Department of Internal Medicine, Konkuk University School of Medicine, Seoul, Korea
Hepatogastroenterology 55:578-81. 2008..4-2% in western countries, this is not well known in Korea. This study aimed to elucidate the rate of natural HbsAg seroclearance, factors associated with seroclearance and prognosis after seroclearance...
Prediction of complete necrosis of hepatocellular carcinoma treated with transarterial chemoembolization prior to liver transplantationSue Jin Kim
Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
Gut Liver 3:285-91. 2009..However, its usefulness has not been fully investigated in the explanted liver...
The Seroconversion Rate of Hepatitis A Virus Vaccination among Patients with Hepatitis B Virus-Related Chronic Liver Disease in KoreaHyun Chin Cho
Division of Gastroenterology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
Gut Liver 5:217-20. 2011..The aim of this study was to evaluate the seroconversion rate of a hepatitis A virus (HAV) vaccination in patients with hepatitis B virus (HBV)-related chronic liver disease (CLD)...
A low viral load predicts a higher initial virologic response to adefovir in patients with Lamivudine-resistant chronic hepatitis BSu Rin Shin
Department of Medicine, Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Sungkyunkwan University School of Medicine, Seoul, Korea
Gut Liver 4:530-6. 2010..However, not all patients who face virologic breakthrough during LAM treatment respond to ADV. The aim of this study was to determine the factors associated with efficacy of ADV in LAM-resistant hepatitis B patients...
Antiviral therapy in patients after treatment for hepatitis C-related hepatocellular carcinomaSu Rin Shin
Department of Medicine, Kangnam Sacred Heart Hospital, College of Medicine, Hallym University, Seoul, Korea
Gut Liver 5:77-81. 2011..We evaluated the efficacy and safety of antiviral therapy following treatment for hepatitis C-related HCC...
[A prospective study on the prevalence and clinical significance of autoantibodies in patients with suspected nonalcoholic fatty liver disease]Dae Hyeon Cho
Department of Medicine, Samsung Medical Center, Seoul, Korea
Korean J Hepatol 11:261-7. 2005..Further studies are necessary to clarify the clinical significance of autoantibody positivity in those patients...
Comparison of the Clinical Features of Hepatitis A between HBsAg-Positive and HBsAg-Negative PatientsKwang Min Kim
Division of Gastroenterology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
Gut Liver 5:500-5. 2011..The aim of this study was to determine the influence of the presence of hepatitis B surface antigen (HBsAg) on the severity of acute hepatitis A...
Superior long-term outcomes after surgery in child-pugh class a patients with single small hepatocellular carcinoma compared to radiofrequency ablationWon Kyoung Yun
Department of Medicine, Samsung Medical Centre, Sungkyunkwan University School of Medicine, Seoul, Korea
Hepatol Int 5:722-9. 2011..There are insufficient data comparing long-term prognoses after radiofrequency ablation (RFA) and surgery...
Rapid quantitative determination of L-FMAU-TP from human peripheral-blood mononuclear cells of hepatitis B virus-infected patients treated with L-FMAU by ion-pairing, reverse-phase, liquid chromatography/electrospray tandem mass spectrometryJaeick Lee
Bioanalysis and Biotransformation Research Center, Korea Institute of Science and Technology, Chungryang, Seoul, Korea
Ther Drug Monit 28:131-7. 2006..The terminal half-life of L-FMAU-TP in PBMCs after drug cessation was estimated to be 15.6 days...
[The prevalence and clinical significance of precore and core promoter mutations in Korean patients with chronic hepatitis B virus infection]Hyung Joon Kim
Department of Gastroenterology, College of Medicine, Chung Ang University, Seoul, Korea
Taehan Kan Hakhoe Chi 8:149-56. 2002..The aims of this study were to determine the prevalence of precore and core promoter mutations and their relationships to hepatitis B e antigen (HBeAg) status, viral replication level, and severity of liver disease in Korea...
Balloon-occluded retrograde transvenous obliteration of gastric varices: outcomes and complications in 49 patientsSung Ki Cho
Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Ilwon dong 50, Kangnam Ku, Seoul 135 710, Korea
AJR Am J Roentgenol 189:W365-72. 2007..Our aim was to evaluate the clinical outcomes, techniques, and complications of balloon-occluded retrograde transvenous obliteration for treating gastric varices with spontaneous gastrosystemic shunts...
[A case of hepatocellular carcinoma complicating cardiac cirrhosis caused by constrictive pericarditis]Pil Sang Song
Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
Korean J Gastroenterol 45:436-40. 2005..To our knowledge, this is the first case of HCC complicating cardiac cirrhosis in Korea...
Twenty-four-week clevudine therapy showed potent and sustained antiviral activity in HBeAg-positive chronic hepatitis BByung Chul Yoo
Samsung Medical Center, Sungkyunkwan University, and Yonsei University Hospital, Seoul, Korea
Hepatology 45:1172-8. 2007..CONCLUSION: A 24-week clevudine therapy was well tolerated and showed potent and sustained antiviral effect without evidence of viral resistance during treatment period in HBeAg-positive chronic hepatitis B...
[Risk factors of morbidity and mortality following surgical resection for hepatocellular carcinoma]Wan Wook Kim
Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Korea
Korean J Hepatol 10:51-61. 2004..Recently, mortality following surgical resection for hepatocellular carcinoma has been reduced significantly. Morbidity, however, is still significant. This study evaluated the risk factors leading to morbidity and mortality...
Glycyrrhizin attenuates HMGB1-induced hepatocyte apoptosis by inhibiting the p38-dependent mitochondrial pathwayGeum Youn Gwak
Department of Medicine, Samsung Medical Center, Sugnkyunkwan University School of Medicine, 50 Irwon dong, Gangnam Gu, 135 710 Seoul, South Korea
World J Gastroenterol 18:679-84. 2012..To examine how high-mobility group box 1 (HMGB1) regulates hepatocyte apoptosis and, furthermore, to determine whether glycyrrhizin (GL), a known HMGB1 inhibitor, prevents HMGB1-induced hepatocyte apoptosis...
Overlapping gene mutations of hepatitis B virus in a chronic hepatitis B patient with hepatitis B surface antigen loss during lamivudine therapySun Young Lee
Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
J Korean Med Sci 20:433-7. 2005..Our result suggests that false HBsAg negativity can be induced by combination of overlapping gene mutations during the lamivudine therapy...
The relationship between apolipoprotein E polymorphism, lipoprotein (a) and fatty liver diseaseMoon Hee Yang
Center for Health Promotion, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
Hepatogastroenterology 52:1832-5. 2005..The purpose of this study was to investigate the relationship between the apo E genotype, plasma Lp(a) level, and fatty liver...
Prognostic significance of p53 overexpression after hepatic resection of hepatocellular carcinomaChang Okh Sung
Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Gangnam-gu, Seoul, Korea
Korean J Gastroenterol 45:425-30. 2005....
Diaphragmatic weakness after transcatheter arterial chemoembolization of inferior phrenic artery for treatment of hepatocellular carcinomaSung Wook Shin
Department of Radiology and Center for Imaging Sciences, Division of Gastroenterology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Ilwon-dong, Kangnam-ku, Seoul 135-710, Korea
Radiology 241:581-8. 2006..CONCLUSION: After TACE of the inferior phrenic artery, a substantial portion of patients showed functional and anatomic evidence of diaphragmatic weakness...
Positive positron emission tomography scan in sarcoidosis and two challenging cases of metastatic cancer. CASE 2. Hepatocellular carcinoma with metastasis to the breastJi-young Rhee
Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
J Clin Oncol 23:8908-9. 2005
Comparing the outcomes of radiofrequency ablation and surgery in patients with a single small hepatocellular carcinoma and well-preserved hepatic functionSung Noh Hong
Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Irwon-dong, Gangnam-gu, Seoul 135-710, Korea
J Clin Gastroenterol 39:247-52. 2005....
[Early diagnosis and improved survival with screening for hepatocellular carcinoma]Chung Mee Youk
Division of Gastroenterology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
Taehan Kan Hakhoe Chi 9:116-23. 2003..4% vs. 70.7%, 2 year; 71.5% vs. 59.9%, p<0.05). CONCLUSIONS: Screening with AFP and US is a useful tool for early diagnosis of HCC, especially with improved survival in Child-Pugh A patients...
Management of chronic hepatitis B with nucleoside or nucleotide analogues: a review of current guidelinesMoon Seok Choi
Division of Gastroenterology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
Gut Liver 4:15-24. 2010..A review of the past and current guidelines for the management of CH-B would be useful for evaluating the current status of management of the disease and to identify better solutions for improving the outcome of patients with CH-B...
Phase II study of doxorubicin and cisplatin in patients with metastatic hepatocellular carcinomaJeeyun Lee
Division of Hematology/Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 135-710, Seoul, Korea
Cancer Chemother Pharmacol 54:385-90. 2004..The objective response rate of the regimen was comparable to those found in other phase II trials, but the search for the optimal chemotherapy should be continued...
Clinicopathologic features and prognosis of combined hepatocellular cholangiocarcinomaKwang Cheol Koh
Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Ilwon-dong 50, Kangnam-ku, Seoul, Korea 135-710
Am J Surg 189:120-5. 2005..CONCLUSIONS: The HCC-CC group has distinct clinicopathologic features compared with the HCC or CC groups. In addition, the HCC-CC group has a prognosis that is better than the CC group but worse than the HCC group...
Local radiotherapy for patients with unresectable hepatocellular carcinomaWon Park
Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
Int J Radiat Oncol Biol Phys 61:1143-50. 2005..CONCLUSIONS: Radiotherapy for unresectable HCC resulted in 66.1% of tumor response with acceptable toxicity, and the radiation dose seems to be a significant prognostic factor in RT response for HCC...
Liver abscess after percutaneous radiofrequency ablation for hepatocellular carcinomas: frequency and risk factorsDongil Choi
Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50, Ilwon-Dong, Kangnam-ku, Seoul 135-710, South Korea
AJR Am J Roentgenol 184:1860-7. 2005....
Promoter methylation of E-cadherin in hepatocellular carcinomas and dysplastic nodulesGhee Young Kwon
Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
J Korean Med Sci 20:242-7. 2005..And the promoter methylation of E-cadherin in HCC was found to be significantly correlated with microvascular invasion and recurrence...
Cyclin E, p27 and mutant p53 do not predict the prognosis in AJCC stage II colorectal carcinomasYun Jeong Lim
Department of Internal Medicine, Sungkyunkwan University School of Medicine, Center for Health Promotion, Samsung Medical Center, Seoul 135-710, Korea
Korean J Gastroenterol 44:314-20. 2004..CONCLUSIONS: Our results suggested that the expression of cyclin E, p27 and mutant p53 proteins did not predict the clinical outcome in the stage II colorectal carcinomas...
Correlation of mutation and immunohistochemistry of p53 in hepatocellular carcinomas in Korean peopleShi Nae Lee
Department of Pathology, Ewha Womans University College of Medicine, Seoul, Korea
J Korean Med Sci 17:801-5. 2002....
A phase II dose-escalating trial of clevudine in patients with chronic hepatitis BPatrick Marcellin
Service d Hepatologie, Hopital Beaujon, Clichy, France
Hepatology 40:140-8. 2004..The pharmacokinetic profile of clevudine was proportional to the dose. In conclusion, these results demonstrate the tolerability and potent activity of clevudine in HBV-infected patients and support further clinical study...
A 12-week clevudine therapy showed potent and durable antiviral activity in HBeAg-positive chronic hepatitis BHyo Suk Lee
Seoul National University Hospital, South Korea
Hepatology 43:982-8. 2006....
Three-dimensional conformal radiotherapy for portal vein thrombosis of hepatocellular carcinomaDae Yong Kim
Research Institute and Hospital, National Cancer Center, Gyeonggi, Korea
Cancer 103:2419-26. 2005..A dose-response relation was found to exist between the RT dose and PVT response. These results suggested that RT may be a treatment option for PVT in patients with HCC and that an RT dose > or = 58 Gy(10) should be recommended...
UGT1A7 haplotype is associated with an increased risk of hepatocellular carcinoma in hepatitis B carriersSun Young Kong
Department of Laboratory Medicine, Center for Clinical Services, Research Institute and Hospital, National Cancer Center, 809 Madu dong, Ilsan gu, Goyang si, Gyeonggi do 410 769, Korea
Cancer Sci 99:340-4. 2008..45 [95% CI; 1.03-2.03] and 4.95 [95% CI; 1.75-13.98], respectively). The results of this study show that the UGT1A7 haplotype is a suitable susceptibility marker for the development of HCC in hepatitis B carriers...
